Brief: Tango Therapeutics reports Q2 results
10/08/2022 12:07
Aug 10 (Reuters) - Tango Therapeutics Inc TNGX.O :
* TANGO THERAPEUTICS REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES BUSINESS HIGHLIGHTS
* TANGO THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.28
Source text for Eikon: ID:nGNX2Wc6lc
Further company coverage: TNGX.O
Recent news on Tango Therapeutics
See all newsBrief: Tango Therapeutics, Inc. Approved A Strategic Reprioritization Of The Company’S Research And Development Activities
Brief: Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Tango Therapeutics - Files Prospectus To Sell Up To $400 Million In Common Stock
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,